Skip to main content
Year archive

ZELIRA THERAPEUTICS LIMITED — 2020 filings

All 81 regulatory filings released by ZELIRA THERAPEUTICS LIMITED (ZLD) in 2020, sourced directly from the official regulator.

81 Filings
2020 Period
2020 filings (81)
Filing Released Lang
Clarification regarding HOPE Distribution to Washington DC 2 pages 176.3KB
Regulatory Filings
2020-12-17 English
Zelira Expands HOPE Distribution to Washington DC, USA 2 pages 181.4KB
Regulatory Filings
2020-12-13 English
R&D Tax Incentive Refund 2 pages 175.6KB
Regulatory Filings
2020-12-10 English
Change of Director's Interest Notice 2 pages 211.2KB
Regulatory Filings
2020-12-10 English
ZLD Partners with SprinJene to Launch CBD Toothpaste in US 3 pages 230.8KB
Regulatory Filings
2020-12-01 English
Cancellation of Unlisted Options 2 pages 162.3KB
Regulatory Filings
2020-11-19 English
Results of Meeting 2 pages 242.7KB
Regulatory Filings
2020-11-12 English
Appendix 3G 13 pages 332.1KB
Regulatory Filings
2020-11-12 English
Emyria Deal and Autism Observational Trial for HOPE Products 3 pages 264.4KB
Regulatory Filings
2020-11-08 English
September 2020 Quarterly Report 5 pages 182.6KB
Regulatory Filings
2020-10-29 English
Appendix 4C - quarterly 5 pages 160.9KB
Regulatory Filings
2020-10-29 English
HOPE launches in Australia after TGA approves release 2 pages 188.1KB
Regulatory Filings
2020-10-26 English
Updated Investor Presentation - Non-Deal Roadshow 17 pages 1.9MB
Regulatory Filings
2020-10-21 English
Cleansing Notice and Appendix 2A 16 pages 486.3KB
Regulatory Filings
2020-10-15 English
Letter to Shareholders re Upcoming Annual General Meeting 1
Regulatory Filings
2020-10-11 English
Notice of Annual General Meeting 21 pages 271.2KB
Regulatory Filings
2020-10-11 English
Becoming a substantial holder - Tiga Trading Pty Ltd 4 pages 163.8KB
Regulatory Filings
2020-09-27 English
Appendix 3G 13 pages 330.1KB
Regulatory Filings
2020-09-24 English
Cleansing Notice and Appendix 2A 16 pages 486.4KB
Regulatory Filings
2020-09-24 English
Thorney Becomes a Substantial Strategic Investor in Zelira 2 pages 209.5KB
Regulatory Filings
2020-09-22 English
Proposed issue of Securities - ZLD 6 pages 31.6KB
Regulatory Filings
2020-09-22 English
Results of Meeting 2 pages 227.6KB
Regulatory Filings
2020-09-16 English
Zenivol launches in Australia after TGA approves release 3 pages 212.3KB
Regulatory Filings
2020-09-15 English
Issue of Unquoted Options 2 pages 155.8KB
Regulatory Filings
2020-09-10 English
Appendix 3G 13 pages 331.6KB
Regulatory Filings
2020-09-10 English
Zelira Presentation ASX Small and Mid-Cap Conference 15 pages 4.5MB
Regulatory Filings
2020-09-09 English
Zelira Forms Subsidiary to Launch Oral Care Products in USA 3 pages 204.1KB
Regulatory Filings
2020-09-07 English
Appendix 4E & Financial Statements 82 pages 1.5MB
Regulatory Filings
2020-08-27 English
Appendix 4G 11 pages 168.1KB
Regulatory Filings
2020-08-27 English
HOPE Range Of Products Launches In Louisiana 2 pages 189.7KB
Regulatory Filings
2020-08-19 English
Change of Director's Interest Notice x2 6 pages 260.5KB
Regulatory Filings
2020-08-13 English
Change in substantial holding 2 pages 145.4KB
Regulatory Filings
2020-08-13 English
Ceasing to be a substantial holder 2 pages 232.3KB
Regulatory Filings
2020-08-13 English
Letter to Shareholders re Upcoming General Meeting 1
Regulatory Filings
2020-08-12 English
Notice of General Meeting 13 pages 208.4KB
Regulatory Filings
2020-08-12 English
Cleansing Notice and Appendix 2A 16 pages 487.1KB
Regulatory Filings
2020-08-10 English
Appendix 3G 13 pages 330.0KB
Regulatory Filings
2020-08-10 English
ZLD Successfully Completes $8.75M Oversubscribed Placement 3 pages 161.3KB
Regulatory Filings
2020-08-02 English
Proposed issue of Securities - ZLD 5 pages 28.0KB
Regulatory Filings
2020-08-02 English
June 2020 Quarterly Report 4 pages 258.9KB
Regulatory Filings
2020-07-29 English
Appendix 4C - quarterly 5 pages 161.9KB
Regulatory Filings
2020-07-29 English
Trading Halt 3 pages 596.9KB
Regulatory Filings
2020-07-28 English
Zelira Enters Deal to Develop Products For Vascular Diseases 6 pages 236.5KB
Regulatory Filings
2020-07-21 English
Results of Meeting 2 pages 261.6KB
Regulatory Filings
2020-07-20 English
Trading Halt 3 pages 376.3KB
Regulatory Filings
2020-07-19 English
Zelira Phase 1 Chronic Pain Trial Meets Clinical Endpoints 4 pages 279.3KB
Regulatory Filings
2020-07-13 English
Director Performance Rights 3 pages 162.9KB
Regulatory Filings
2020-07-09 English
Proposed issue of Securities - ZLD 5 pages 28.4KB
Regulatory Filings
2020-07-09 English
Investor Presentation - Non-deal Roadshow 16 pages 5.0MB
Regulatory Filings
2020-07-08 English
ZLD to form partnership for chronic pain in retired athletes 4 pages 157.7KB
Regulatory Filings
2020-06-16 English
Letter to Shareholders 1 page 172.2KB
Regulatory Filings
2020-06-16 English
Notice of General Meeting 22 pages 322.1KB
Regulatory Filings
2020-06-16 English
Proposed issue of Securities - ZLD 11 pages 44.9KB
Regulatory Filings
2020-06-16 English
Finalisation of Appointment Details - Managing Director, USA 3 pages 203.9KB
Regulatory Filings
2020-06-02 English
TasAlk to Manufacture Zeliras Insomnia and HOPE products 3 pages 159.4KB
Regulatory Filings
2020-05-25 English
Investor Presentation - Non-deal Roadshow 27 pages 5.3MB
Regulatory Filings
2020-04-30 English
March 2020 Quarterly Report 4 pages 173.6KB
Regulatory Filings
2020-04-29 English
Appendix 4C - quarterly 5 pages 173.1KB
Regulatory Filings
2020-04-29 English
Insomnia Phase 2 Clinical Trial Presentation 15 pages 3.2MB
Regulatory Filings
2020-04-07 English
Insomnia Trial Meets Primary and Secondary Endpoints 6 pages 709.1KB
Regulatory Filings
2020-04-06 English
Zelira Therapeutics Insomnia Clinical Trial Media Release 4 pages 328.2KB
Regulatory Filings
2020-04-06 English
Appendix 4D & FY20 Interim Financial Report 28 pages 1.0MB
Regulatory Filings
2020-02-27 English
Zelira Meets Primary Endpoints for Insomnia Trial 5 pages 250.0KB
Regulatory Filings
2020-02-18 English
Appendix 2A and Cleansing Notice 16 pages 494.2KB
Regulatory Filings
2020-02-18 English
Capital Raising Update 2 pages 126.8KB
Regulatory Filings
2020-02-16 English
Proposed issue of Securities - ZLD 5 pages 27.8KB
Regulatory Filings
2020-02-16 English
Trading Halt 3 pages 235.4KB
Regulatory Filings
2020-02-16 English
Expiry of unlisted options 2 pages 122.9KB
Regulatory Filings
2020-02-06 English
Appendix 2A 15 pages 283.3KB
Regulatory Filings
2020-02-05 English
Cleansing Notice 1 page 205.4KB
Regulatory Filings
2020-02-05 English
Zelira Successfully Completes Capital Raising of $4.6M 2 pages 160.2KB
Regulatory Filings
2020-02-04 English
Proposed issue of Securities - ZLD 5 pages 28.1KB
Regulatory Filings
2020-02-04 English
Trading Halt 3 pages 198.4KB
Regulatory Filings
2020-02-02 English
December 2019 Quarterly Report 6 pages 126.9KB
Regulatory Filings
2020-01-30 English
Appendix 4C - quarterly 6 pages 221.3KB
Regulatory Filings
2020-01-30 English
Zelira to Collaborate with the Parkinsons Foundation 3 pages 170.5KB
Regulatory Filings
2020-01-27 English
Ceasing to be a substantial holder 2 pages 154.1KB
Regulatory Filings
2020-01-16 English
Change in substantial holding 4 pages 396.2KB
Regulatory Filings
2020-01-09 English
Notification of Expiry of Unlisted Options 3 pages 179.1KB
Regulatory Filings
2020-01-01 English
Appendix 3B and Cleansing Notice 15 pages 491.2KB
Regulatory Filings
2020-01-01 English
Change of Director's Interest Notice x 3 9 pages 259.6KB
Regulatory Filings
2020-01-01 English